HCA Healthcare, Inc.

(New York Stock Exchange)

Top News rankings and signal summaries are processed using AI and may contain errors.

21
Slightly Bearish -15

HCA Healthcare stock faces flat 2027 outlook as payer pressure grows

Company update Financial outlook AI-generated analysis

HCA Healthcare is entering 2027 with resilient patient demand but faces a preliminary earnings outlook indicating limited growth momentum. Management expects full-year service volume to grow between 2% and 3%, driven by continued demand, though profit expansion is being constrained by weaker payer economics. The...

Bullish Signals

  • Patient demand resilient; service volume expected to grow 2% to 3% in 2027.
  • Q3 revenue $19.849B; net income $1.579B for period ended Sept 30, 2026.

Bearish Signals

  • Payer economics limit profit momentum vs 2026 levels.
  • Uninsured care shift cut Q3 pre-tax income $400M.
  • Medicaid benefits drop $550M-$650M in 2027.
22
Somewhat Bullish +45

HCA Healthcare stock: 24 analysts give HCA Healthcare stock a USD 467.61 consensus target

Stock valuation AI-generated analysis

HCA Healthcare is the subject of a consensus analyst target price report, with 24 analysts setting a USD 467.61 average target as of October 17, 2026. This valuation represents a slight premium of 1.54% over the stock's trading price of USD 460.51 recorded on October...

Bullish Signals

  • Analysts set a $467.61 target price.
  • Stock trades 29.82% above its 52-week low.

Bearish Signals

  • Stock trades 17.25% below 52-week high of USD 556.52.
  • Dividend yield is low at 0.70%.
23
Bullish +55

HCA Healthcare stock steadies near USD 427.71

AI-generated analysis

HCA Healthcare stock closed at USD 427.71 on September 18, 2026, marking a slight decline of 0.31 percent from the previous session's close of USD 429.04. The company operates within the Health Care Services and Health Care Facilities sectors, maintaining a market capitalization of approximately...

Bullish Signals

  • Q2 FY26 revenue reached USD 20.23 billion.
  • Diluted EPS hit USD 6.85 in Q2 FY26.
  • Stock trades below USD 452.29 fair value.

Bearish Signals

  • Stock declined 0.31% to USD 427.71 on Sept 18, 2026.
  • Price below previous close of USD 429.04 due to selling pressure.
24
Slightly Bullish +25

TD Cowen Cuts PT on HCA Healthcare (HCA) But Remains Bullish

AI-generated analysis

TD Cowen has lowered its price target for HCA Healthcare (NYSE: HCA) from $500 to $431 while maintaining a Buy rating. The firm adjusted its growth assumptions for 2026 and 2027 downward following a May hospital survey that indicated flat year-over-year revenue growth. The survey...

Bullish Signals

  • TD Cowen maintains Buy rating on HCA Healthcare.
  • HCA identified as best non-tech stock to buy.
  • Medical volume growth offsets weaker surgical volumes.
  • HCA acquires College of Health Care Professions.

Bearish Signals

  • TD Cowen cut HCA price target from $500 to $431.
  • Growth assumptions lowered for 2026-2027 due to flat May revenue.
  • Surgical volumes weakened per latest hospital survey data.
25
Slightly Bullish +20

HCA Healthcare (HCA) Stock Forecast & Price Target (2026)

Earnings report AI-generated analysis

HCA Healthcare (HCA) is currently trading at $451.09 as of October 11, 2026, with analyst consensus and CleaRank Financial AI fair value estimates both set at $450.00, resulting in a 'Hold' rating. Technical indicators show the stock trading above its 50-day average of $420.71 with...

Bullish Signals

  • Beat Q2 2026 EPS estimates by 1.2%.
  • Stock rose 1.94% on positive earnings momentum.
  • Trading above key moving averages with bullish RSI.
  • P/E ratio significantly lower than sector median.

Bearish Signals

  • Insiders sold $38.5M, signaling short-term lack of confidence.
  • Poor profitability metrics temper undervaluation thesis despite low P/E.